Gene Lay

Sr. VP Life Sciences
Revvity


​

Dr. Gene Lay is Senior Vice President, Life Sciences at Revvity. As both a scientist and a strategic business leader, Gene leads a team responsible for shaping the Company’s Life Sciences portfolio and delivering solutions that accelerate breakthrough discoveries across therapeutic areas. Gene joined Revvity as part of the Company’s acquisition of BioLegend, the company he founded in June 2002 that’s recognized as a leader in the development of high-quality antibodies for cellular immunity. He served as the President and Chief Executive Officer of BioLegend since January 2003.
Gene has always been fascinated by the immune system’s ability to heal the body, and in 2023, he founded The Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School. Immunology and biomedical experts from the three institutions are working together to translate research discoveries into therapies for immune-related diseases rooted in chronic inflammation.
Prior to founding BioLegend, Gene co-founded PharMingen, Inc., a leading life science research reagents company, in 1987, where he served as Senior Vice President of Operations. In 1997, upon PharMingen’s acquisition by Becton, Dickinson and Company (BD Bioscience), Gene continued to serve as Vice President of Operations through 2002. Gene received the 2016 EY Entrepreneur of the Year® Award in San Diego in Life Sciences and was a National Finalist in the same category. Gene received a Master of Science degree in Microbiology/Immunology from the University of Louisiana, Lafayette, and a Doctor of Veterinary Medicine (D.V.M.) from the Veterinary School at the National Pingtung University of Science and Technology in Taiwan. He holds honorary doctoral degrees from National Pingtung University of Science and Technology and National Yang Ming Chiao Tung University.

 

Speech title & Synopsis

Entrepreneurship- My Journey in Biotechnology

.